Janssen has a strong commitment to patients and we take our corporate responsibility seriously. Patients have always been at the heart of everything we do. Our approach includes gaining clear insight of patient needs.  Collaborating with patients and advocacy organizations is critical to capturing perspectives as we develop and deliver medicines and solutions to meet their needs. We work alongside with healthcare professionals in addition to patient organizations, to facilitate education, awareness, support and assistance to patients.

These relationships function in accordance with a number of important principles such as mutual respect, integrity, independence and transparency.

Principles for Interactions with Patient Organizations 

To ensure that our interactions with patient organizations are conducted in an ethical, compliant and transparent manner, we are guided by applicable local laws, the Johnson & Johnson Code of Business Conduct, relevant Janssen internal policies and applicable Innovative Medicines Canada (IMC) codes and guidelines.

Please review our exclusionary criteria.

Submission Process

Visit our Grant Portal to submit a patient organization request.

For all questions related to grants and giving please contact [email protected].

Deadlines

Submission deadline:

Please note that our Patient Organization grants portal will be closed to new 2023 applications as of September 22, 2023. Applications for the 2024 calendar will be received as of November 15, 2023. As with previous years, all submissions must be received 60 days prior to the start date of the activity/project.

Funding decisions:

Following an internal review process, you will be notified of the status of your application within 60 days of a completed submission and no additional information is required.

Transparency:

To view funding provided to patient organizations in 2023, please click here.